Nippon Chemiphar Co (TSE:4539) EBIT: 円446 Mil (TTM As of Mar. 2026)


TSE:4539 Nippon Chemiphar Co Ltd TSE:4539
59 GF Score
Price 円1,692.00
GF Value 円1,705.64
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Nippon Chemiphar Co EBIT?

Nippon Chemiphar Co TSE:4539 +1.38% 59 EBIT is 円446 Mil as of Mar. 2026. GuruFocus rates TSE:4539 with a GF Score™ of 59/100 and a GF Value™ of 円1,705.64 (Fairly Valued). The stock has 9 warning signs investors should review.

Nippon Chemiphar Co's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was 円129 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円446 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nippon Chemiphar Co's annualized ROC % for the quarter that ended in Mar. 2026 was 0.28%. Nippon Chemiphar Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 0.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nippon Chemiphar Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.57%.


Nippon Chemiphar Co  (TSE:4539) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nippon Chemiphar Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=114 * ( 1 - 0% )/( (40128 + 42286)/ 2 )
=114/41207
=0.28 %

where

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Nippon Chemiphar Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=258/( ( (14361 + max(13515, 0)) + (14326 + max(15254, 0)) )/ 2 )
=258/( ( 27876 + 29580 )/ 2 )
=258/28728
=0.90 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7097 + 12421 + 4035) - (2857 + 0 + 7181)
=13515

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8179 + 12892 + 3528) - (2350 + 0 + 6995)
=15254

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nippon Chemiphar Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=446/17375.087
=2.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Chemiphar Co EBIT Related Terms


Nippon Chemiphar Co EBIT Historical Data

* Premium members only.

The historical data trend for Nippon Chemiphar Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nippon Chemiphar Co EBIT Chart

Nippon Chemiphar Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,094.00 602.00 -52.00 451.00 446.00

Nippon Chemiphar Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -148.00 28.00 423.00 317.00 129.00

TSE:4539 vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Chemiphar Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Chemiphar Co EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Chemiphar Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nippon Chemiphar Co's EV-to-EBIT falls into.


TSE:4539
59GF Score
Nippon Chemiphar Co Ltd TSE:4539
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nippon Chemiphar Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円446 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円446 Mil mean?
Nippon Chemiphar Co (TSE:4539) has a EBIT of 円446 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nippon Chemiphar Co.
Is Nippon Chemiphar Co's EBIT too high?
Nippon Chemiphar Co's current EBIT is 円446 Mil. Overall, Nippon Chemiphar Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nippon Chemiphar Co's EBIT compare to ZTS and UTHR?
Nippon Chemiphar Co's EBIT of 円446 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nippon Chemiphar Co. Nippon Chemiphar Co's current EBIT is 円446 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Chemiphar Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Chemiphar Co (TSE:4539) is currently considered Fairly Valued. The stock's GF Value™ is 円1,705.64, compared to a current price of 円1,692.00 — trading 0.8% below its estimated fair value. The current EBIT is 円446 Mil. Nippon Chemiphar Co's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nippon Chemiphar Co (TSE:4539), the current EBIT is 円446 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nippon Chemiphar Co (TSE:4539) Overvalued in 2026?

Based on GuruFocus' analysis, Nippon Chemiphar Co stock appears to be undervalued. The current stock price of 円1,692.00 is trading 0.8% below its estimated GF Value™ of 円1,705.64. GuruFocus considers Nippon Chemiphar Co to be Fairly Valued.

Key valuation signals for TSE:4539:

  • EBIT: 円446 Mil
  • GF Value™: 円1,705.64 vs. price of 円1,692.00 (0.8% below fair value)
  • GF Score™: 59/100 with 9 warning signs

No single metric tells the full story. See the TSE:4539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nippon Chemiphar Co Business Description

Address 2-2-3, Iwamoto-cho, Chiyoda-ku, Tokyo, JPN, 101-0032
Nippon Chemiphar Co Ltd produces and sells medicines for medical use. The company also produces medical, health and cosmetics products. Nippon Chemiphar sterilizes medical instruments for hospitals and operates nursing home for elderly.
59GF Score

Get the complete analysis for TSE:4539

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,692.00
Price
円1,705.64
GF Value